Evidence map›Paper›PMID 24285684›Full record

ArticleThe Journal of clinical endocrinology and metabolism2014

Lower expression of the TWIK-related acid-sensitive K+ channel 2 (TASK-2) gene is a hallmark of aldosterone-producing adenoma causing human primary aldosteronism.

Livia Lenzini, Brasilina Caroccia, Abril González Campos, Ambrogio Fassina, Anna S Belloni, Teresa M Seccia, Maniselvan Kuppusamy, Silvia Ferraro, Ghizlane Skander, Michael Bader and 2 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 55 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Regulation of Corticosteroidogenic Genes by MicroRNAs.International journal of endocrinology · 2017
    Article
  15. Review
  16. Issues in the Diagnosis and Treatment of Primary Aldosteronism.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2016
    Review
  17. Article
  18. Two-pore domain potassium channels in the adrenal cortex.Pflugers Archiv : European journal of physiology · 2015
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Livia LenziniInternal Medicine 4 (L.L., B.C., A.G.C., T.M.S., M.K., S.F., G.S., G.P.R.) and Surgical Pathology and Cytopathology Unit (A.F.), Department of Medicine, Department of Medicine, Section of Human Anatomy and Physiology (A.S.B.), Department of Molecular Medicine, University of Padua, 35128 Padua, Italy; Max-Delbrück-Center for Molecular Medicine (M.B.), 13092 Berlin, Germany; and Department of Molecular and Integrative Physiology (W.E.R.), University of Michigan, Ann Arbor, Michigan 48109.
Brasilina Caroccia
Abril González Campos
Ambrogio Fassina
Anna S Belloni
Teresa M Seccia
Maniselvan Kuppusamy
Silvia Ferraro
Ghizlane Skander
Michael Bader
William E Rainey
Gian Paolo Rossi
University of Padua · ITMax Delbrück Center · DEUniversity of Michigan–Ann Arbor · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextThe molecular mechanisms of primary aldosteronism, a common cause of human hypertension, are unknown, but alterations of K(+) channels can play a key role.

objectiveThe objective of the study was to investigate the following: 1) the expression of the Twik-related acid-sensitive K(+) channels (TASK) in aldosterone producing adenomas (APAs); 2) the role of TASK-2 in aldosterone synthesis; and 3) the determinants of TASK-2-blunted expression in APAs.

designWe analyzed the transcriptome and the microRNA profiles of 32 consecutive APAs and investigated the protein expression and localization of TASK-2 in APA and adrenocortical cell lines (H295R and HAC15) using immunoblotting and confocal microscopy. The functional effect of TASK-2 blunted activity caused by a dominant-negative mutation on steroidogenic enzymes, and aldosterone production was also assessed. TASK-2 regulation by selected microRNA was studied by a luciferase assay.

resultsTASK-2 was consistently less expressed at the transcript and protein levels in APAs than in the normal human adrenal cortex. H295R cell transfection with a TASK-2 dominant-negative mutant construct significantly increased the aldosterone production by 153% and the gene expression of aldosterone synthase (CYP11B2, gene expression fold change 3.1 vs control, P < .05) and the steroidogenic acute regulatory protein (gene expression fold change 1.8 vs control, P < .05). Two microRNAs, hsa-miR-23 and hsa-miR-34, were found to decrease the TASK-2 expression by binding to the 3' untranslated region of the TASK-2 gene.

conclusionsThe TASK-2 channel lower expression represents a hallmark of APA and is associated with a higher expression of hsa-miR-23 and hsa-miR-34. The ensuing blunted TASK-2 activity increased the production of aldosterone in vitro and the expression of steroidogenic acute regulatory protein and CYP11B2. Hence, the lower expression of TASK-2 channel in APA cells can explain high aldosterone secretion in human primary aldosteronism despite the suppression of angiotensin II, hypertension, and hypokalemia.

Indexed as

AdenomaAdrenal Cortex NeoplasmsAldosteroneCells, CulturedDown-RegulationGene Expression ProfilingGene Expression Regulation, NeoplasticHEK293 CellsHumansHyperaldosteronismMicroarray AnalysisParaneoplastic Endocrine SyndromesPotassium Channels, Tandem Pore DomainAldosteroneKCNK5 protein, humanPotassium Channels, Tandem Pore Domain

Identifiers

PMID24285684
OpenAlexW1987591029

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.